1515 — China Resources Medical Holdings Income Statement
0.000.00%
- HK$4.38bn
- HK$6.83bn
- CNY10.11bn
- 51
- 84
- 13
- 47
Annual income statement for China Resources Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,115 | 2,751 | 4,447 | 7,901 | 10,108 |
Cost of Revenue | |||||
Gross Profit | 762 | 637 | 934 | 1,306 | 1,906 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,559 | 2,342 | 4,237 | 7,495 | 9,574 |
Operating Profit | 556 | 408 | 210 | 406 | 534 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 541 | 418 | 270 | 423 | 493 |
Provision for Income Taxes | |||||
Net Income After Taxes | 401 | 320 | 426 | 328 | 328 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 391 | 310 | 418 | 266 | 258 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 391 | 310 | 418 | 266 | 258 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.312 | 0.241 | 0.446 | 0.291 | 0.458 |
Dividends per Share |